Turbine Receives Investment from Accenture
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Simulated Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Accenture Ventures makes a strategic investment in Turbine, a company pioneering the use of predictive cell simulations for drug development.
— Companies will co-develop inhibitors of a dark kinase target (NEK1) identified for cancer dependency by Turbine’s Simulated Cell™ platform — LONDON & BUDAPEST, Hungary & NEW YORK--(BUSINESS WIRE)--Turbine, a company that is building the world’s first predictive simulation...
-- Enhanced financial resources and expertise will further Turbine's interpretable simulation research and maximize the potential of its Simulated Cell™ platform -- Turbine's proprietary approach pairs
Turbine’s AI-powered Cancer Cell Simulations Will Be Used to Identify Novel Disease Positioning Strategies in Cancer Research UK’s Latest Biotech Partnership LONDON & BUDAPEST, Hungary – Cancer Research Horizons, the innovation engine at the core of the world’s largest private funder...